Treatment outcomes of radiotherapy for patients with stage I esophageal cancer: A single institute experience

Tomonari Sasaki, Katsumasa Nakamura, Yoshiyuki Shioyama, Yasushi Toh, Ken Okamura, Hiroki Ohura, Hideki Hirata, Hiroshi Honda

    Research output: Contribution to journalArticle

    10 Citations (Scopus)

    Abstract

    OBJECTIVES: To evaluate the effectiveness of radiotherapy for patients with stage I esophageal cancer. METHODS: From 1995 to 2005, 34 patients with superficial thoracic esophageal squamous cell carcinoma without lymph node metastasis were treated with radiotherapy at our institute. Patient characteristics were as follows: median age, 68 years; range, 47 to 84 years; male:female, 33:1; performance status, 0/1/2/3 = 23/9/1/1; T1a/T1b = 4/30. Median fraction and total doses of external irradiation given were 2.0 Gy and 60 Gy, respectively. Twenty-three patients had local irradiation to the primary lesion only; the remaining 11 patients received regional field irradiation, including one or 2 regional lymph node areas. Only one patient received adjuvant intracavitary radiotherapy after radiotherapy. Thirty of the patients received concurrent chemotherapy, most of the regimens of which included cisplatin and 5-fluorouracil. Adjuvant chemotherapy was performed in 5 patients. Fifteen patients (44%) had coexisting malignancies. The median follow-up was 38 months (range, 8-107 months). RESULTS: The 5-year overall, cause-specific, and local-progression-free survival rates were 50.4%, 91.2%, and 81.1%, respectively. Of the 34 patients, 6 had in-field local recurrence, and one had recurrence in the esophagus outside of the irradiated field. Two patients experienced regional lymph node metastasis outside of the irradiated field, and one had distant metastasis. Two patients received salvage surgery, and 4 patients received salvage intracavitary radiotherapy after local recurrence. A late toxicity greater than grade 2 was not observed in any patient. CONCLUSIONS: Radiotherapy is an effective treatment modality for patients with stage I esophageal cancer.

    Original languageEnglish
    Pages (from-to)514-519
    Number of pages6
    JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
    Volume30
    Issue number5
    DOIs
    Publication statusPublished - Oct 1 2007

    All Science Journal Classification (ASJC) codes

    • Oncology
    • Cancer Research

    Fingerprint Dive into the research topics of 'Treatment outcomes of radiotherapy for patients with stage I esophageal cancer: A single institute experience'. Together they form a unique fingerprint.

  • Cite this